CY2231B1 - Compositions of oak bark extract related syntheticcompositions and method of using same - Google Patents

Compositions of oak bark extract related syntheticcompositions and method of using same

Info

Publication number
CY2231B1
CY2231B1 CY0100022A CY0100022A CY2231B1 CY 2231 B1 CY2231 B1 CY 2231B1 CY 0100022 A CY0100022 A CY 0100022A CY 0100022 A CY0100022 A CY 0100022A CY 2231 B1 CY2231 B1 CY 2231B1
Authority
CY
Cyprus
Prior art keywords
oak bark
bark extract
ions
syntheticcompositions
compositions
Prior art date
Application number
CY0100022A
Other languages
English (en)
Inventor
David N S Hon
R Thomas Stanley
Original Assignee
Greystone Medical Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greystone Medical Group Inc filed Critical Greystone Medical Group Inc
Publication of CY2231B1 publication Critical patent/CY2231B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Oncology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Laminated Bodies (AREA)
  • Road Paving Structures (AREA)
CY0100022A 1992-11-06 2001-08-31 Compositions of oak bark extract related syntheticcompositions and method of using same CY2231B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97307192A 1992-11-06 1992-11-06

Publications (1)

Publication Number Publication Date
CY2231B1 true CY2231B1 (en) 2003-04-18

Family

ID=25520460

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0100022A CY2231B1 (en) 1992-11-06 2001-08-31 Compositions of oak bark extract related syntheticcompositions and method of using same

Country Status (21)

Country Link
US (1) US6149947A (fr)
EP (1) EP0668769B1 (fr)
JP (1) JP3640215B2 (fr)
AT (1) ATE191850T1 (fr)
AU (1) AU700019B2 (fr)
BR (1) BR9307401A (fr)
CA (1) CA2148795C (fr)
CY (1) CY2231B1 (fr)
CZ (1) CZ117395A3 (fr)
DE (1) DE69328438T2 (fr)
DK (1) DK0668769T3 (fr)
ES (1) ES2147780T3 (fr)
HU (1) HUT73791A (fr)
MX (1) MX9306960A (fr)
NO (1) NO951740L (fr)
NZ (1) NZ258019A (fr)
OA (1) OA10153A (fr)
PL (1) PL308770A1 (fr)
PT (1) PT668769E (fr)
WO (1) WO1994011010A2 (fr)
ZA (1) ZA938274B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7014870B1 (en) * 1992-11-06 2006-03-21 Greystone Medical Group, Inc. Compositions of oak bark extract related synthetic compositions and method of using same
AUPN104895A0 (en) * 1995-02-10 1995-03-09 Lai, John Methods of and preparations for the treatment of ailments and disorders
US20040037898A1 (en) * 1997-10-08 2004-02-26 Hon David N.S Compositions of oak bark extract, related synthetic compositions and method of using same
US20050033251A1 (en) * 1998-12-08 2005-02-10 Quick-Med Technologies, Inc. Controlled release of biologically active substances from select substrates
US20040170703A1 (en) * 2001-11-29 2004-09-02 Greystone Medical Group, Inc. Reduction of reactive oxygen species in chronic wound management
MXPA04005219A (es) * 2001-11-29 2005-06-20 Greystone Medical Group Inc Tratamiento de heridas y composiciones empleadas.
US6667026B1 (en) 2002-03-15 2003-12-23 Pocono Falls, Inc. Allergic contact dermatitis treatment and composition therefor
WO2003099218A2 (fr) * 2002-05-24 2003-12-04 Greystone Medical Group, Inc. Preparation anticancereuse
JP2006511585A (ja) * 2002-12-23 2006-04-06 グレイストーン メディカル グループ、インコーポレイテッド 慢性創傷管理における活性酸素種の減少
WO2005000328A1 (fr) * 2003-06-24 2005-01-06 Zanti Gianfranco Compositions a base de cendres vegetales destinees au traitement de maladies de la peau
US20060105017A1 (en) * 2004-06-22 2006-05-18 Greystone Medical Group, Inc. Methods for treatment of wounds using time release compositions
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
EP1993569B1 (fr) 2006-02-03 2014-07-23 OMP, Inc. Traitement anti-vieillissement utilisant des préparations de cuivre et de zinc
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
CA2700990C (fr) * 2007-03-15 2014-08-12 Om Kataria Batonnets de stimulant uterin
EP2211868B1 (fr) 2007-10-15 2017-08-02 7 Oaks Pharmaceutical Corporation Compositions à base de silicate pour le traitement de mélanome
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
US20160184354A1 (en) 2009-01-23 2016-06-30 Jr Chem, Llc Rosacea treatments and kits for performing them
US20110200655A1 (en) * 2010-02-16 2011-08-18 Michael Darryl Black Systems and methods that kill infectious agents (bacteria) without the use of a systemic anti-biotic
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US8828449B2 (en) 2012-01-26 2014-09-09 Libby Robinson Wound dressing composition and method of use
US9351995B1 (en) 2011-04-29 2016-05-31 Red Oax Holdings, LLC Compositions and methods of enhancing wound healing
WO2013012968A1 (fr) 2011-07-20 2013-01-24 3M Innovative Properties Company Pansement avec composition portant des ions
US20140194803A1 (en) * 2011-07-28 2014-07-10 Regents Of The University Of Minnestoa Wound-healing compositions and method of use
WO2013025579A2 (fr) 2011-08-17 2013-02-21 3M Innovative Properties Company Fibres comportant des monomères greffés et leurs utilisations
GB201402672D0 (en) 2014-02-14 2014-04-02 Medical Res Council Materials and methods relating to stabilised polymeric silicate compositions
WO2016123539A1 (fr) 2015-01-29 2016-08-04 Wardell Mark R Compositions pour cicatrisation des plaies comprenant du miel ayant des propriétés médicinales, des ions minéraux et du méthylglyoxal, et leurs procédés d'utilisation
HRP20240085T1 (hr) * 2019-03-04 2024-03-29 Aurealis Therapeutics AG Prokariotski ekspresijski sustav indukciran kloridom
IT201900018047A1 (it) * 2019-10-07 2021-04-07 Nello Vallicella Procedimento per la preparazione di una composizione topica liquida.
WO2024196897A1 (fr) * 2023-03-22 2024-09-26 Courtland Imel Nouveaux procédés pour accroître la vitesse de cicatrisation des plaies chez l'humain et les animaux

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US55911A (en) * 1866-06-26 Improved medical compound
US202246A (en) * 1878-04-09 Improvement in medical compounds
US37901A (en) * 1863-03-17 Improved liniment
US256847A (en) * 1882-04-25 Salve
DE819127C (de) * 1949-09-28 1951-10-29 Heinz Dr Bauer Verfahren zur Herstellung eines Heilbades gegen Hautekzeme
DE812341C (de) * 1950-03-07 1951-08-27 Penicillin Ges Dauelsberg & Co Verfahren zur Herstellung eines Hautbehandlungsmittels
DE833840C (de) * 1950-06-01 1952-03-13 Dr Heinz Bauer Verfahren zur Herstellung einer Salbe gegen Hautekzeme
US3928584A (en) * 1969-06-30 1975-12-23 Us Health Education & Welfare Extracts from active tree saps for treating P388 mouse leukemia
US4059695A (en) * 1974-02-14 1977-11-22 Kanari Hirosaki Method for manufacturing a tonic composition for man and other animals
JPS60164467A (ja) * 1984-02-07 1985-08-27 Rooman Kogyo:Kk 飲料
DE3584837D1 (de) * 1985-10-08 1992-01-16 Psori Med Ag Salzmischung zur behandlung der schuppenflechte (psoriasis) und anderer hautkrankheiten.
US4847083A (en) * 1986-04-02 1989-07-11 Dermasciences, Inc. Two-step procedure for indolent wound healing and aqueous medium and topical ointment used in connection therewith
BE1000950A3 (fr) * 1987-10-05 1989-05-23 Claude Patricia Produit de beaute saliaris au sel de la mer morte et a l'argile verte de haute provence.
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
US5080900A (en) * 1990-04-17 1992-01-14 Stanley R Thomas Treatment of skin ulcers with an aqueous extract of oak bark ash

Also Published As

Publication number Publication date
WO1994011010A2 (fr) 1994-05-26
PT668769E (pt) 2000-10-31
CA2148795A1 (fr) 1994-05-26
DE69328438T2 (de) 2001-01-04
WO1994011010A3 (fr) 1994-09-15
BR9307401A (pt) 1999-08-24
US6149947A (en) 2000-11-21
ZA938274B (en) 1994-06-09
NZ258019A (en) 1998-12-23
EP0668769A1 (fr) 1995-08-30
NO951740L (no) 1995-06-19
AU700019B2 (en) 1998-12-17
ATE191850T1 (de) 2000-05-15
HUT73791A (en) 1996-09-30
JP3640215B2 (ja) 2005-04-20
NO951740D0 (no) 1995-05-04
JPH08503462A (ja) 1996-04-16
DK0668769T3 (da) 2000-10-02
ES2147780T3 (es) 2000-10-01
AU5550094A (en) 1994-06-08
HU9501323D0 (en) 1996-05-28
EP0668769B1 (fr) 2000-04-19
PL308770A1 (en) 1995-08-21
MX9306960A (es) 1995-01-31
CZ117395A3 (en) 1995-11-15
CA2148795C (fr) 2004-08-10
DE69328438D1 (de) 2000-05-25
OA10153A (en) 1996-12-18

Similar Documents

Publication Publication Date Title
ZA938274B (en) Compositions of oak bark extract related synthetic compositions and method of using same
WO1994011010B1 (fr) Compositions a base d'extrait d'ecorse de chene, compositions synthetiques associees, et procede d'utilisation de ces compositions
AU1974888A (en) Glycerol and diglycerol mixtures for skin moisturising
GR3006001T3 (fr)
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
EP0325129A3 (en) Disubstituted pyridines
AU553269B2 (en) 2,3-diaryl-5-halo thiophenes
DE59306051D1 (de) Verwendung von radikalfängern als immunmodulierende agentien in kosmetischen und dermatologischen zubereitungen
DE3687838D1 (de) Deodorant-bettmaterial.
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana
NZ220495A (en) A2a cyclopeptan-2-ones carrier containing methotrexate compositions
EP0572549A4 (fr)
DE3485282D1 (de) Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren.
AU588227B2 (en) Hair growth stimulating agents and their use
MX9405923A (es) Mejoras en proceso para humectar y suavizar la piel.
GR3024709T3 (en) Novel cytarabine derivatives, their production and use